Back to results
US 2004/0171659 A1Published application
Methods for treating diabetes
OwnerSatyanarayana Medicherla, Andrew A. Protter +1inventors
InventorsSatyanarayana Medicherla, Andrew A. Protter, George F. Schreiner
Life of this patent
Estimating the term…
Abstract
The invention is directed to methods of treating diabetes by administering p38 mitogen activated protein kinase inhibitors. The invention is also directed to methods of decreasing blood glucose level in diabetes patients by administering p38 mitogen activated protein kinase inhibitors.
Claims11
A method of preventing Type I diabetes, comprising:
- identifying a subject susceptible to Type I diabetes;
- and
- administering to the subject a pharmaceutically effective amount of a p38 mitogen activated protein (MAP) kinase inhibitor sufficient to prevent onset of Type I diabetes.
A method of decreasing blood glucose levels, comprising:
- providing to a subject with elevated blood glucose levels with a pharmaceutically effective amount of a p38 mitogen activated protein (MAP) kinase inhibitor sufficient to decrease blood glucose level in said patient.
A method of inhibiting body weight loss in a subject suffering from Type I diabetes, comprising:
- identifying the subject suffering from to Type I diabetes;
- and
- providing the subject with a pharmaceutically effective amount of a p38 mitogen activated protein (MAP) kinase inhibitor sufficient to inhibit body weight loss in the subject.
Dependencies are inferred from the claim text.